Close

Precipio (PRPO) Signs Additional Major HemeScreen Customer

Go back to Precipio (PRPO) Signs Additional Major HemeScreen Customer

Precipio Signs Additional Major HemeScreen™ Customer

December 6, 2022 10:00 AM EST

NEW HAVEN, Conn., Dec. 06, 2022 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announced a 4-year agreement with a new customer to bring HemeScreen technology... More